Alcohol withdrawal
Authors:
- 1 September 1995
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 10 (9) , 479-487
Abstract
OBJECTIVE: To describe current practices employed in the inpatient treatment for alcohol withdrawal. DESIGN: Survey. SETTING: Inpatient alcoholism treatment programs in the United States. PARTICIPANTS: Medical directors of 176 (69%) of 257 eligible programs randomly selected from a national listing. RESULTS: The medical directors estimated that of all inpatients treated for alcohol withdrawal at the programs, 68% received one of the following medications. Benzodiazepines, including the long-acting chlordiazepoxide (33%) and diazepam (16%), and less frequently the short-acting oxazepam (7%) and lorazepam (4%), were the most commonly used agents. Barbiturates (11%), phenytoin (10%), clonidine (7%), (5-blockers (3%), carbamazepine (1%), and antipsychotics (1%) were less frequently given. Drug was most often given on a fixed dosing schedule with additional medication “as needed” (52% of the programs). Only 31% of the programs routinely used a standardized withdrawal severity scale to monitor patients. Mean duration of sedative treatment was three days; inpatient treatment, four days. Use of fixed-schedule regimens was associated with longer sedative treatment (mean four vs three days, pCONCLUSIONS: The most commonly reported regimen for alcohol withdrawal included three days of long-acting benzodiazepines on a fixed schedule with additional medication “as needed.” Standardized monitoring of the severity of withdrawal was not common practice. The directors reported using a variety of other regimens, some not known to prevent the major complications of withdrawal. Although geographic location and director specialty were significantly associated with treatment duration, much of the variation in treatment for alcohol withdrawal remains unexplained.Keywords
This publication has 16 references indexed in Scilit:
- Individualized Treatment for Alcohol WithdrawalJAMA, 1994
- The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizuresAnnals of Emergency Medicine, 1994
- Transdermal Clonidine Versus Chlordiazepoxide in Alcohol WithdrawalSouthern Medical Journal, 1991
- Barbiturates and alcohol withdrawalJournal of General Internal Medicine, 1990
- Detoxification of Alcoholics: Improving Care by Symptom‐Triggered SedationAlcohol, Clinical and Experimental Research, 1990
- Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizuresThe American Journal of Medicine, 1989
- Alcohol withdrawal syndromesJournal of General Internal Medicine, 1989
- Use of an Objective Clinical Scale in the Assessment and Management of Alcohol Withdrawal in a Large General HospitalAlcohol, Clinical and Experimental Research, 1988
- Randomized Clinical Trial of Atenolol in Patients with Alcohol WithdrawalNew England Journal of Medicine, 1985
- Deficiencies of Clinical Trials of Alcohol WithdrawalAlcohol, Clinical and Experimental Research, 1983